Insights into entamoeba histolytica virulence modulation

Infectious Disorders - Drug Targets

Volumn 10, Issue 4, 2010, Pages 242-250

  Padilla Vaca, F ^a   Anaya Velazquez F ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Entamoeba histolytica; Pathogenicity; Virulence modulation

Indexed keywords

HEMOLYSIN; MUCIN; VIRULENCE FACTOR;

AMEBIASIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOLOGICAL ACTIVITY; ENTAMOEBA HISTOLYTICA; GENE EXPRESSION; IN VITRO STUDY; MOLECULAR MECHANICS; MUTANT; NONHUMAN; PATHOGENICITY; PHENOTYPE; PROTEIN DEGRADATION; VIRULENCE;

EID: 77958599076     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152610791591638     Document Type: Article

References (117)

1. Pritt, B. S.; Clark, C. G. Amebiasis. Mayo Clin. Proc., 2008, 83, 1154-1160.
2. Martínez-Palomo, A. The biology of Entamoeba histolytica. ResearchStudies Press: Chichester, 1982.
3. World Health Organization. Amoebiasis. Weekly Epidemiol. Rec., 1997, 72, 97-99.
4. Espinosa-Cantellano, M.; Martínez-Palomo, A. Pathogenesis ofintestinal amebiasis: from molecules to disease. Clin. Microbiol. Rev., 2000, 13, 318-31.
5. Anaya-Velázquez, F.; Martínez-Palomo, A.; Tsutsumi, V.; González-Robles, A. Intestinal invasive amebiasis: an experimentalmodel in rodents using axenic or monoxenic strains of Entamoebahistolytica. Am. J. Trop. Med. Hyg., 1985, 34, 723-30.
6. Salles, J. M.; Moraes, L. A.; Salles, M. C. Hepatic amebiasis. BrazilianJ. Infect. Dis., 2003, 7, 96-110.
7. Bansal, D.; Ave, P.; Kerneis, S.; Frileux, P.; Boché, O., Baglin, A. C.; Dubost, G.; Leguern, A. S.; Prevost, M. C.; Bracha, R.; Mirelman, D.; Guillén, N.; Labruyère, E. An ex vivo human intestinalmodel to study Entamoeba histolytica pathogenesis. PloS Negl. Trop. Dis., 2009, 3, e551. doi:10.1371/journal.pntd.0000551.
8. Guo, X.; Houpt, E.; Petri, W. A. Jr. Crosstalk at the initial encounter:Interplay between host defense and ameba survival strategies. Curr. Opin. Immunol., 2007, 19, 376-384.
9. Sacks, D.; Sher, A. Evasion of innate immunity by parasitic protozoa. Nature Immunol., 2002, 3, 1041-7.
10. Debnath, A.; Tashker, J. S.; Sajid, M.; McKerrow, J. H. Transcriptionaland secretory responses of Entamoeba histolytica to mucins, epithelial cells and bacteria. Int. J. Parasitol., 2007, 37, 897-906.
11. Chen, Y.; Cheng, X. J. Advances in research on virulence factors ofEntamoeba histolytica. Zhongguo Ji Sheng Chong Xue Yu Ji ShengChong Bing Za Zhi., 2006, 24, 457-460.
12. Montfort, I.; Olivos, A.; Pérez-Tamayo, R. Phagocytosis andproteinase activity are not related to pathogenicity of Entamoebahistolytica. Arch. Med. Res., 1992, 23, 177-179.
13. Ankri, S.; Padilla-Vaca, F.; Stolarsky, T.; Koole, L.; Katz, U.; Mirelman, D. Antisense inhibition of expression of the lightsubunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoebahistolytica virulence. Mol. Microbiol., 1999, 33, 327-337.
14. Ankri, S.; Stolarsky, T.; Bracha, R.; Padilla-Vaca, F.; Mirelman, D. Antisense inhibition of expression of cysteine proteinases affectsEntamoeba histolytica-induced formation of liver abscess in hamsters. Infect. Immun., 1999, 67, 421-422.
15. Bracha, R.; Nuchamowitz, Y.; Leippe, M.; Mirelman, D. Antisenseinhibition of amoebapore expression in Entamoeba histolyticacauses a decrease in amoebic virulence. Mol. Microbiol., 1999, 34, 463-472.
16. Olivos-García, A.; Saavedra, E.; Ramos-Martínez, E.; Nequiz, M.; Pérez-Tamayo, R. Molecular nature of virulence in Entamoeba histolytica. Infect. Genet. Evol., 2009, 9(6), 1033-1037.
17. Ramos-Martínez, E.; Olivos-García, A.; Saavedra, E.; Nequiz, M.; Sánchez, E. C.; Tello, E.; El-Hafidi, M.; Saralegui, A.; Pineda, E.; Delgado, J.; Montfort, I.; Pérez-Tamayo, R. Entamoeba histolytica:oxygen resistance and virulence. Int. J. Parasitol., 2009, 39, 693-702.
18. Mirelman, D.; Ankri, S.; Katz, U.; Padilla-Vaca, F.; Bracha, R. Pathogenesis of Entamoeba histolytica depends on the concertedaction of numerous virulence factors. Arch. Med. Res., 2000, 31, S214-15.
19. Petri, W. A. Jr.; Haque, R.; Mann, B. J. The bittersweet interface ofparasite and host: lectin-carbohydrate interactions during humaninvasion by the parasite Entamoeba histolytica. Ann. Rev. Microbiol., 2002, 56, 39-64.
20. Frederick, J. R.; Petri, W. A. Jr. Roles for the galactose-/Nacetylgalactosaminebinding lectin of Entamoeba in parasite virulenceand differentiation. Glycobiol., 2005, 15, 53R-59R.
21. Leippe, M. Amebapores. Parasitol. Today, 1997, 13, 178-83.
22. Que, X.; Reed, S. L. Cysteine proteinases and the pathogenesis ofamebiasis. Clin. Microbiol. Rev., 2000, 13, 196-206.
23. Diamond, L. S. In In vitro cultivation of protozoan parasites; Jensen, J. B., Ed.; CRC Press: Boca Raton, 1983; pp. 65-110.
24. Tsutsumi, V.; Ramirez-Rosales, A.; Gonzales-Mendoza, H.; Shibayama, M.; Chavez, B.; Rangel-Lopez, E. Entamoeba histolytica:erythrophagocytosis, collagenolysis and liver abscess production asvirulence markers. Trans. Roy. Soc. Trop. Med. Hyg., 1992, 86, 170-2.
25. Lujan, H. D.; Diamond, L. S. Cholesterol requirement and metabolismin Entamoeba histolytica. Arch. Med. Res., 1997, 28, 96-7.
26. Mirelman, D. In Amebiasis: Human Infection by Entamoeba histolytica. Ravdin, J. I., Ed.; John Wiley and Sons, Inc.: New York,1988; pp. 351-69.
27. Mendoza-Macías, C. L.; Barrios-Ceballos, M. P.; Cárdenas de laPeña, L. P.; Rangel-Serrano, A.; Anaya-Velázquez, F.; Mirelman, D.; Padilla-Vaca, F. Entamoeba histolytica: Effect on virulence, growth and gene expression in response to monoxenic culture withEscherichia coli O55. Exp. Parasitol., 2009, 121, 167-74.
28. Petri, W. A.; Chapman, M. D.; Snodgrass, T.; Mann, B. J.; Broman, J.; Ravdin, J. I. Subunit structure of the galactose and N-acetyl-Dgalactosamine-inhibitable adherence lectin of Entamoeba histolytica. J. Biol. Chem., 1989, 264, 3007-3012.
29. Cheng, X. J.; Hughes, M. A.; Huston, C. D.; Loftus, B.; Gilchrist, C. A.; Lockhart, L. A.; Ghosh, S.; Miller-Sims, V.; Mann, B. J.; Petri, W. A. Jr.; Tachibana, H. Intermediate subunit of theGal/GalNAc lectin of Entamoeba histolytica is a member of a genefamily containing multiple CXXC sequence motifs. Infect. Immun., 2001, 69, 5892-5898.
30. Ravdin, J. I.; Guerrant, R. L. Role of adherence in cytopathicmechanisms of Entamoeba histolytica. Study with mammalian tissueculture cells and human erythrocytes. J. Clin. Invest., 1981, 68, 1305-1313.
31. Bracha, R.; Mirelman, D. Virulence of Entamoeba histolyticatrophozoites. Effects of bacteria, microaerobic conditions and metronidazole. J. Exp. Med., 1984, 160, 353-386.
32. Chadee, K.; Petri, W. A.; Innes, D. J.; Ravdin, J. I. Rat and humancolonic mucins bind to and inhibit the adherence lectin of Entamoebahistolytica. J. Clin. Invest., 1987, 80, 1245-54.
33. Burchard, G. D.; Bilke, R. Adherence of pathogenic and nonpathogenicEntamoeba histolytica strains to neutrophils. Parasitol. Res., 1992, 78, 146-153.
34. Braga, L. L.; Ninomiya, H.; McCoy, J. J.; Eacker, S.; Wiedmer, T.; Pham, C.; Wood, S.; Sims, P. J.; Petri, W. A. Jr. Inhibition of thecomplement membrane attack complex by the galactose-specificadhesin of Entamoeba histolytica. J. Clin. Invest., 1992, 90, 1131-1137.
35. Vines, R. R.; Ramakrishnan, G.; Rogers, J. B.; Lockhart, L. A.; Mann, B. J.; Petri, W. A. Jr. Regulation of adherence and virulenceby the Entamoeba histolytica lectin cytoplasmic domain, whichcontains a cc2 integrin motif. Mol. Biol. Cell, 1998, 9, 2069-2079.
36. Padilla-Vaca, F.; Ankri, S.; Bracha, R.; Koole, L. A.; Mirelman, D. Down regulation of Entamoeba histolytica virulence by monoxeniccultivation with Escherichia coli O55 is related to a decrease in expressionof the light (35-kilodalton) subunit of the Gal/GalNAclectin. Infec. Immun., 1999, 67, 2096-2102.
37. García-Rivera, G.; Rodríguez, M. A.; Ocádiz, R.; Martínez-López, M. C.; Arroyo, R.; González-Robles, A.; Orozco, E. Entamoeba histolytica:a novel cysteine protease and an adhesin form the 112 kDasurface protein. Mol. Microbiol., 1999, 33, 556-568.
38. Martínez-López, C.; Orozco, E.; Sánchez, T.; García-Pérez, R. M.; Hernández-Hernández, F.; Rodríguez, M. A. The EhADH112 recombinantpolypeptide inhibits cell destruction and liver abscessformation by Entamoeba histolytica trophozoites. Cell Microbiol., 2004, 6, 367-76.
39. Leippe, M.; Tannich, E.; Nickel, R.; van der Goot, G.; Pattus, F.; Horstmann, R. D.; Muller-Eberhard, H. J. Primary and secondarystructure of the pore-forming peptide of pathogenic Entamoeba histolytica. EMBO J., 1992, 11, 3501-3506.
40. Andra, J.; Leippe, M. Pore-forming peptide of Entamoeba histolytica:significance of positively charged amino acid residues for itsmode of action. FEBS Lett., 1994, 354, 97-102.
41. Leippe, M.; Andra, J.; Nickel, R.; Tannich, E.; Muller-Eberhard, H. J. Amoebapores, a family of membranolytic peptides from cytoplasmicgranules of Entamoeba histolytica: isolation, primarystructure, and pore formation in bacterial cytoplasmic membranes. Mol. Microbiol., 1994, 14, 895-904.
42. Leippe, M.; Andra, J.; Muller-Eberhard, H. J. Cytolytic and antibacterialactivity of synthetic peptides derived from amoebapore, thepore-forming peptide of Entamoeba histolytica. Proc. Natl. Acad. Sci. USA, 1994, 91, 2602-6.
43. Leippe, M.; Sievertsen, H. J.; Tannich, E.; Horstmann, R. D. Spontaneousrelease of cysteine proteinases but not of pore-formingpeptides by viable Entamoeba histolytica. Parasitol., 1995, 111, 569-574.
44. Tannich, E. Entamoeba histolytica and E. dispar: comparison ofmolecules considered important for host tissue destruction. Trans. R. Soc. Trop. Med. Hyg., 1998, 92, 593-596.
45. Zhang, X.; Zhang, Z.; Alexander, D.; Bracha, R.; Mirelman, D.; Stanley, S. L. Jr. Expression of Amoebapores Is Required for FullExpression of Entamoeba histolytica Virulence in Amebic LiverAbscess but Is Not Necessary for the Induction of Inflammation orTissue Damage in Amebic Colitis. Infec. Immun., 2004, 72, 678-683.
46. Bracha, R.; Nuchamowitz, Y.; Mirelman, D. Transcriptional silencingof an amoebapore gene in Entamoeba histolytica: molecularanalysis and effect on pathogenicity. Eukaryot. Cell, 2003, 2, 295-305.
47. Lushbaugh, W. B.; Hofbauer, A. F.; Pittman, F. E. Entamoeba histolytica:purification of cathepsin B. Exp. Parasitol., 1985, 59, 328-336.
48. Luaces, A. L.; Barret, A. J. Affinity purification and biochemicalcharacterization of histolysin, the major cysteine protease of Entamoebahistolytica. Biochem. J., 1988, 250, 903-909.
49. Keene, W. E.; Hidalgo, M. E.; Orozco, E.; McKerrow, J. H. Entamoebahistolytica: correlation of the cytopathic effect of virulenttrophozoites with secretion of cysteine proteinase. Exp. Parasitol., 1990, 71, 199-206.
50. Lauwaet, T.; Oliveira, M. J.; Callewaert, B.; De Bruyne, G.; Mareel, M.; Leroy, A. Proteinase inhibitors TPCK and TLCK prevent Entamoebahistolytica disturbance of tight junctions and microvilli inenteric cell layers in vitro. Int. J. Parasitol., 2004, 34, 785-794.
51. Takeuchi, A.; Phillips, B. P. Electron microscope studies of experimentalEntamoeba histolytica infections in the guinea pig. I. Penetrationof the intestinal epithelium by trophozoites. Am. J. Trop. Med. Hyg., 1975, 24, 34-48.
52. Schulte, W.; Scholze, H. Action of the major protease from Entamoebahistolytica on proteins of the extracellular matrix. J. Protozool., 1989, 36, 538-543.
53. Moncada, D.; Keller, K.; Chadee, K. Entamoeba histolytica cysteineproteinases disrupt the polymeric structure of colonic mucinand alter its protective function. Infect. Immun., 2003, 71, 838-844.
54. Moncada, D.; Keller, K.; Ankri, S.; Mirelman, D.; Chadee, K. Antisense inhibition of Entamoeba histolytica cysteine proteasesinhibits colonic mucus degradation. Gastroenterol., 2006, 130, 721-30.
55. Reed, S. L.; Keene, W. E.; McKerrow, J. H.; Gigli, I. Cleavage of C3by a neutral cysteine proteinase of Entamoeba histolytica. J. Immunol., 1989, 143, 189-195.
56. Reed, S. L.; Ember, J. A.; Herdman, D. S.; DiScipio, R. G.; Hugli, T. E.; Gigli, I. The extracellular neutral cysteine proteinase of Entamoebahistolytica degrades anaphylatoxins C3a and C5a. J. Immunol., 1995, 155, 266-274.
57. Tran, V. Q.; Herdman, D. S.; Torian, B. E.; Reed, S. L. The neutralcysteine proteinase of Entamoeba histolytica degrades IgG andprevents its binding. J. Infect. Dis., 1998, 177, 508-511.
58. Kelsall, B. L.; Ravdin, J. I. Degradation of human IgA by Entamoebahistolytica. J. Infect. Dis., 1993, 168, 1319-1322.
59. Que, X.; Kim, S. H.; Sajid, M.; Eckmann, L.; Dinarello, C. A.; McKerrow, J. H.; Reed, S. L. A surface amebic cysteine proteinaseinactivates interleukin-18. Infect. Immun., 2003, 71, 1274-1280.
60. Clark, C. G.; Alsmark, U. C.; Tazreiter, M. Structure and content ofthe Entamoeba histolytica genome. Adv. Parasitol., 2007, 65, 51-190.
61. Bruchhaus, I.; Jacobs, T.; Leippe, M.; Tannich, E. Entamoebahistolytica and Entamoeba dispar: differences in numbers and expressionof cysteine proteinase genes. Mol. Microbiol., 1996, 22, 255-263.
62. Bruchhaus, I.; Loftus, B. J.; Hall, N.; Tannich, E. The intestinalprotozoan parasite Entamoeba histolytica contains 20 cysteine proteasegenes, of which only a small subset is expressed during in vitrocultivation. Eukaryot. Cell, 2003, 2, 501-509.
63. Tillack, M.; Biller, L.; Irmer, H. The Entamoeba histolytica genome:primary structure and expression of proteolytic enzymes. BMC Genomics., 2007, 8, 170.
64. Irmer, H.; Tillack, M.; Biller, L.; Handal, G.; Leippe, M.; Roeder, T.; Tannich, E.; Bruchhaus, I. Major cysteine peptidases of Entamoebahistolytica are required for aggregation and digestion oferythrocytes but are dispensable for phagocytosis and cytopathogenicity. Mol. Microbiol., 2009, 72, 658-667.
65. Davis, P. H.; Schulze, J.; Stanley, S. L. Jr. Transcriptomic comparisonof two Entamoeba histolytica strains with defined virulencephenotypes identifies new virulence factor candidates and key differencesin the expression patterns of cysteine proteases, lectin lightchains, and calmodulin. Mol. Biochem. Parasitol., 2007, 151, 118-128.
66. Hirata, K.; Que, X.; Meléndez-López, S. G.; Debnath, A.; Myers, S.; Herdman, S.; Orozco, E.; Bhattacharya, A.; McKerrow, J.; Reed, S. L. A phagocytosis mutant of Entamoeba histolytica is lessvirulent due to deficient proteinase expression and release. Exp. Parasitol., 2007, 115, 192-199.
67. Gilchrist, C. A.; Houpt, E.; Trapaidze, N.; Fei, Z.; Crasta, O.; Asgharpour, A.; Evans, C.; Martino-Catt, S.; Baba, D. J.; Stroup, S.; Hamano, S.; Ehrenkaufer, G.; Okada, M.; Singh, U.; Nozaki, T.; Mann, B. J.; Petri, W. A. Jr. Impact of intestinal colonization and invasionon the Entamoeba histolytica transcriptome. Mol. Biochem. Parasitol. 2006, 147, 163-176.
68. Navarro-García, F.; Chávez-Dueñas, L.; Tsutsumi, V.; Posadas delRío, F.; López-Revilla, R. Entamoeba histolytica: increase of enterotoxicityand of 53- and 75-kDa cysteine proteinases in a cloneof higher virulence. Exp. Parasitol., 1995, 80, 361-372.
69. Ocádiz, R.; Orozco, E.; Carrillo, E.; Quintas, L. I.; Ortega-López, J.; García-Pérez, R. M.; Sánchez, T.; Castillo-Juárez, B. A.; García-Rivera, G.; Rodríguez, M. A. EhCP112 is an Entamoeba histolyticasecreted cysteine protease that may be involved in the parasitevirulence. Cell Microbiol., 2005, 7, 221-232.
70. Muñoz, M. L.; Calderón, J.; Rojkind, M. The collagenase of Entamoebahistolytica. J. Exp. Med., 1982, 155, 42-51.
71. Martínez-Palomo, A.; Meza, I.; Chávez, B.; Rosales-Encina, J. L.; Muñoz, M. L.; González-Robles, A.; Rojkind, M. In: Entamoebahistolytica: activation and release of membrane dense bodies. Chang, K. P., Snary, D. Eds. Host-parasite cellular and molecularinteractions in protozoal infections. Springer-Verlag KG, Heidelberg, Germany. 1987; pp. 371-76.
72. Gadasi, H.; Kessler, E. Correlation of virulence and collagenolyticactivity in Entamoeba histolytica. Infect. Immun., 1983, 39, 528-31.
73. Muñoz, M. L.; Rojkind, M.; Calderón, J.; Tanimoto, M.; Arias-Negrete, S.; Martínez-Palomo, A. Entamoeba histolytica: collagenolyticactivity and virulence. J. Protozool., 1984, 31, 468-470.
74. Serrano, J. J.; de la Garza, M.; Moreno, M. A.; Tovar, R.; Leon, G.; Tsutsumi, V.; Muñoz, M. Entamoeba histolytica: electron-densegranule secretion, collagenase activity and virulence are altered inthe cytoskeleton mutant BG-3. Mol. Microbiol., 1994, 11, 787-792.
75. Baxt, L. A.; Baker, R. P.; Singh, U.; Urban, S. An Entamoebahistolytica rhomboid protease with atypical specificity cleaves asurface lectin involved in phagocytosis and immune evasion. GenesDev., 2008, 22, 1636-1646.
76. Barrios-Ceballos, M. P.; Martínez-Gallardo, N. A.; Anaya-Velázquez, F.; Mirelman, D.; Padilla-Vaca, F. A novel proteasefrom Entamoeba histolytica homologous to members of the familyS28 of serine proteases. Exp. Parasitol., 2005, 110, 270-275.
77. Bhattacharya, A.; Prasad, R.; Sacks, D. L. Identification and partialcharacterization of a lipophosphoglycan from a pathogenic strain ofEntamoeba histolytica. Mol. Biochem. Parasitol., 1992, 56, 161-168.
78. Stanley, S. L.; Huizenga Jr., H.; Li, E. Isolation and partial characterizationof a surface glycoconjugate of Entamoeba histolytica. Mol. Biochem. Parasitol., 1992, 50, 127-138.
79. Moody-Haupt, S.; Patterson, J. H.; Mirelman, D.; McConville, M. J. The major surface antigens of Entamoeba histolytica trophozoitesare GPI-anchored proteophosphoglycans. J. Mol. Biol., 2000, 24, 409-420.
80. Srivastava, G.; Anand, M. T.; Bhattacharya, S.; Bhattacharya, A. Lipophosphoglycan is present in distinctly different form in differentEntamoeba histolytica strains and absent in Entamoebamoshkovskii and Entamoeba invadens. J. Eukaryot. Microbiol., 1995, 42, 617-622.
81. Moody, S.; Becker, S.; Nuchamowitz, Y.; Mirelman, D. Virulentand avirulent Entamoeba histolytica and E. dispar differ in theircell surface phosphorylated glycolipids. Parasitol., 1997, 114, 95-104.
82. Zhang, Z.; Michael Duchene, M.; Stanley, S. L. Jr. A Monoclonalantibody to the amebic lipophosphoglycan-proteophosphoglycanantigens can prevent disease in human intestinal xenografts infectedwith Entamoeba histolytica. Infect. Immun., 2002, 70, 5873-5876.
83. Lotter, H.; González-Roldán, N.; Lindner, B.; Winau, F.; Isibasi, A.; Moreno-Lafont, M.; Ulmer, A. J.; Holst, O.; Tannich, E.; Jacobs, T. Natural Killer T Cells Activated by a Lipopeptidophosphoglycanfrom Entamoeba histolytica Are Critically Important ToControl Amebic Liver Abscess. PLoS Pathogens., 2009, 5, www.plospathogens.org
84. Said-Fernández, S.; López-Revilla, R. Free fatty acids releasedfrom phospholipids are the major heat-stable hemolytic factor ofEntamoeba histolytica trophozoites. Infect. Immun., 1988, 56, 874-879.
85. Vargas-Villarreal, J.; Olvera-Rodríguez, A.; Mata-Cárdenas, B. D.; Martínez-Rogríguez, H. G.; Said-Fernández, S.; Alagón-Cano, A. Isolation of an Entamoeba histolytica intracellular alkaline phospholipaseA2. Parasitol. Res., 1998, 84, 310-314.
86. Moncada, D. M.; Kammanadiminti, S. J.; Chadee, K. Mucin andToll-like receptors in host defense against intestinal parasites. Trends Parasitol., 2003, 19, 305-311.
87. Belley, A.; Keller, K.; GottKe, M.; Chadee, K. Intestinal mucins incolonization and host defense against pathogens. Am. J. Trop. Med. Hyg., 1999, 60, 10-15.
88. Tse, S. K.; Chadee, K. Biochemical characterization of rat colonicmucins secreted in response to Entamoeba histolytica. Infect. Immun., 1992, 60, 1603-12.
89. Anaya-Velazquez, F.; Padilla-Vaca, F. Effect of intestinal bacteriaon the virulence of Entamoeba histolytica. Arch. Med. Res., 1992, 23, 183-185.
90. Bhattacharya, A.; Ghildyal, R.; Prasad, J.; Bhattacharya, S.; Diamond, L. S. Modulation of a surface antigen of Entamoeba histolyticain response to bacteria. Infect. Immun., 1992, 60, 1711-3.
91. Bhattacharya, A.; Anand, M. T.; Jayshree, P.; Yadav, N.; Bhattacharya, S. Molecular changes in Entamoeba histolytica in response tobacteria. J. Eukaryot. Microbiol., 1998, 45, 28S-33S.
92. Byers, J.; Faigle, W.; Eichinger, D. Colonic short-chain fatty acidsinhibit encystation of Entamoeba invadens. Cell Microbiol., 2005, 7, 269-279.
93. Hackney, J. A.; Ehrenkaufer, G. M.; Singh, U. Identification ofputative transcriptional regulatory networks in Entamoeba histolyticausing Bayesian inference. Nucleic Acids Res., 2007, 35, 2141-2152.
94. Ali, I. K.; Ehrenkaufer, G. M.; Hackney, J. A.; Singh, U. Growth ofthe protozoan parasite Entamoeba histolytica in 5-azacytidine haslimited effects on parasite gene expression. BMC Genomics, 2007, 8, 7.
95. Isakov, E.; Siman-Tov, R.; Weber, C. Trichostatin A regulatesperoxiredoxin expression and virulence of the parasite Entamoebahistolytica. Mol. Biochem. Parasitol., 2008, 158, 82-94.
96. Ehrenkaufer, G. M.; Haque, R.; Hackney, J. A. Identification ofdevelopmentally regulated genes in Entamoeba histolytica: insightsinto mechanisms of stage conversion in a protozoan parasite. CellMicrobiol., 2007, 9, 1426-44.
97. MacFarlane, R. C.; Singh, U. Identification of differentially expressedgenes in virulent and nonvirulent entamoeba species: potentialimplications for amebic pathogenesis. Infect. Immun., 2006, 74, 340-51.
98. Davis, PH.; Zhang, X.; Guo, J.; Townsend, R. R.; Stanley, S. L. Jr. Comparative proteomic analysis of two Entamoeba histolyticastrains with different virulence phenotypes identifies peroxiredoxinas an important component of amoebic virulence. Mol. Microbiol., 2006, 61, 1523-32.
99. Biller, L.; Schmidt, H.; Krause, E.; Gelhaus, C.; Matthiesen, J.; Handal, G.; Lotter, H.; Janssen, O.; Tannich, E.; Bruchhaus, I. Comparison of two genetically related Entamoeba histolytica celllines derived from the same isolate with different pathogenic properties. Proteomics, 2009, 9, 4107-20.
100. Mirelman, D.; Anbar, M.; Bracha, R. Epigenetic transcriptionalgene silencing in Entamoeba histolytica. IUBMB Life., 2008, 60, 598-604.
101. Willhoeft, U.; Buss, H.; Tannich, E. Genetic differences betweenEntamoeba histolytica and Entamoeba dispar. Arch. Med. Res., 2000, 31, S254.
102. Clark, C. G.; Diamond, L. S. Entamoeba histolytica: An explanationfor the reported conversion of "nonpathogenic" amebae to the"pathogenic" form. Exp. Parasitol., 1993, 77, 456-60.
103. Diamond, L. S.; Clark, C. G. A redescription of Entamoeba histolyticaSchaudinn, 1903 (Emended Walker, 1911) separating it fromEntamoeba dispar Brumpt, 1925. J. Eukaryot. Microbiol., 1993, 40, 340-4.
104. Clark, C. G.; Diamond, L. S. Methods for cultivation of luminalparasitic protists of clinical importance. Clin. Microbiol. Rev., 2002, 15, 329-41.
105. Espinosa-Cantellano, M.; González-Robles, A.; Chávez, B.; Castañón, G.; Argüello, C.; Lázaro-Haller, A.; Martínez-Palomo, A. Entamoeba dispar: ultrastructure, surface properties and cytopathiceffect. J. Eukaryot. Microbiol., 1998, 45, 265-72.
106. Mitra, B. N.; Yasuda, T.; Kobayashi, S.; Saito-Nakano, Y.; Nozaki, T. Differences in morphology of phagosomes and kinetics of acidificationand degradation in phagosomes between the pathogenicEntamoeba histolytica and the non-pathogenic Entamoeba dispar. Cell Motil. Cytoskeleton., 2005, 62, 84-99.
107. Leippe, M.; Bahr, E.; Tannich, E.; Horstmann, R. D. Comparison ofpore-forming peptides from pathogenic and nonpathogenic Entamoebahistolytica. Mol. Biochem. Parasitol., 1993, 59, 101-9.
108. Tannich, E. Amoebic disease Entamoeba histolytica and E dispar:comparison of molecules considered important for host tissue destruction. Trans. Roy. Soc. Trop. Med. Hyg., 1998, 92, 593-6.
109. Jackson, T. F. H. G.; Ravdin, J. I. Differentiation of Entamoebahistolytica and Entamoeba dispar infections. Parasitol. Today, 1996, 12, 406-9.
110. Tanyuksel, M.; Petri, W. A. Jr. Laboratory diagnosis of amebiasis. Clin. Microbiol. Rev., 2003, 16, 713-29.
111. MacFarlane, R. C.; Singh, U. Identification of differentially expressedgenes in virulent and nonvirulent Entamoeba species: potentialimplications for amebic pathogenesis. Infect. Immun., 2006, 74, 340-51.
112. Leitsch, D.; Wilson, I. B.; Paschinger, K.; Duchêne, M. Comparisonof the proteome profiles of Entamoeba histolytica and its close butnon-pathogenic relative Entamoeba dispar. Wien. Klin. Wochenschr., 2006, 118, 37-41.
113. Mirelman, D.; Bracha, R.; Chayen, A.; Aust-Kettis, A.; Diamond, L. S. Entamoeba histolytica: effect of growth conditions and bacterialassociates on isoenzyme patterns and virulence. Exp. Parasitol., 1986, 62, 142-8.
114. Mirelman, D.; Bracha, R.; Wexler, A.; Chayen, A. Changes inisoenzyme patterns of a cloned culture of nonpathogenic Entamoebahistolytica during axenization. Infect. Immun., 1986, 54, 827-32.
115. Acuña-Soto, R.; Samuelson, J.; De Girolami, P.; Zarate, L.; Millan-Velasco, F.; Schoolnick, G.; Wirth, D. Application of the polymerasechain reaction to the epidemiology of pathogenic and nonpathogenicEntamoeba histolytica. Am. J. Trop. Med. Hyg., 1993, 48, 58-70.
116. Fotedar, R.; Stark, D.; Beebe, N.; Marriott, D.; Ellis, J.; Harkness, J. Laboratory diagnostic techniques for Entamoeba species. Clin. Microbiol. Rev., 2007, 20, 511-32.
117. Shibayama, M.; Dolabella, S. S.; Silva, E. F.; Tsutsumi, V. A. Brazilianspecies of Entamoeba dispar (ADO) produces amoebic liverabscess in hamsters. Ann. Hepatol., 2007, 6, 117-8.